Charities We Support


We are proud to commit toward organizations that are dedicated to helping people and solving world problems.  We feel the commitment of “% of sales” is the best way to ensure customers can have confidence that their purchase is making a difference.

We plan to introduce special colors to support important charities, enabling our customers to participate in funding the causes that matter most to them.



Each year, we participate in Erie Gives to support local non-profits that share in our vision to make Erie, Pennsylvania even more amazing!  We applaud our 2016 recipients including Environment Erie, Erie Art Museum, and Innovation Collaborative. 



2016-recap-kids-logov2-250px.png    environmenterie-logo.png


reCAP KIDS & Environment Erie Partnership

Mason Jars Company, makers of reCAP, is partnering with Environment Erie to raise awareness of environmental responsibility, to promote sustainability, and to share creative and eco-friendly uses for Mason jars. Mason Jars Company joined 1% for the Planet, pledging to donate 1% of annual sales to support non-profit organizations, like Environment Erie, focused on sustainability.

The two teams launched their relationship with a kick-off celebration on March 8th, 2015 at the Tom Ridge Center.  According to reCAP Founder, Karen Rzepecki, “There are a lot of opportunities to give, but this particular organization is near and dear to our heart.As part of our participation in 1% for the Planet, Environment Erie is one of the organizations to receive both monetary and product donations. One of our core goals is to achieve Zero Waste, and together, we share in a passion to make the world a better place.”


Follow reCAP on Facebook to hear more about upcoming events with Environment Erie!


Mason Jars Company Announces Partnership with 1% for the Planet

Erie PA, July 1, 2014 we joined 1% for the Planet, pledging to donate 1% of annual reCAPⓇ KIDS sales to support non-profit organizations focused on sustainability.

About 1% for the Planet

1% for the Planet is a global network of businesses that donate one percent of annual sales directly to approved environmental and sustainability nonprofit organizations. Over 1200 member companies in 48 countries give back to this big blue planet through over 3600 nonprofit partners.  Started in 2002 by Yvon Chouinard, founder of Patagonia, and Craig Mathews, owner of Blue Ribbon Flies, 1% for the Planet helps people buy better products and protect the planet we play on.  To date, the network has given over $100 million back to blue. To learn more go to:




Supporting the Kanzius Cancer Research Foundation

Our first charity color was pink, to support breast cancer awareness.  Proceeds went to Kanzius Cancer Research Foundation.  In June 2014, they successfully completed their mission to bring the Noninvasive Radiowave Cancer Treatment to human trials.  This will allow the treatment of cancer patients noninvasively and with no side effects. 


The goal of Kanzius Cancer Research Foundation is to raise the funds necessary to support ongoing research of the Kanzius Noninvasive Radiowave Cancer Treatment. Ultimately, we strive to bring the treatment to and through human trials, to treat cancer patients noninvasively and with no side effects. 


Triple-negative breast cancer is an especially challenging type of breast cancer that is difficult to treat traditionally. Stuart J. Corr, PhD and Postdoctoral Research Associate explained that “triple-negative breast cancer is different from other breast cancers in that it does not have surface receptors, or ‘ears’ and ‘eyes’ for the cell, to intake traditional hormone and drug treatments. This characteristic makes these treatments ineffective.”  However, Corr also pointed out the potential use of noninvasive radiofrequency (RF) cancer therapy.  “Radiowaves, such as those you tune into using the car radio, can penetrate deep into breast tissue without causing adverse side effects. Our recent work has shown that RF energy causes an 'interesting effect' in animal breast cancer tumors – it dilates and opens up the tumor blood networks allowing more chemotherapeutics to get inside. In theory, this effectively means we can decrease chemotherapy dosage, increase the efficacy and reduce the negative side effects of chemotherapy.” 

Pancreatic cancer and liver cancer in large non-human subjects are undergoing extensive research in Houston. In addition, studies on breast cancer, colon cancer, leukemia, lung cancer, melanoma, osteosarcoma, and prostate cancer are being conducted in both Houston and Pittsburgh. Research Institutions and Projects»

To learn more about the research please request Published Journal Articles or explore Research Updates.




Recent Updates